Folate (Vitamin B9) 用于 Coronary Artery Disease (CAD)
CCSPPT showed stroke benefit but not MI benefit. HOPE-2 was negative for cardiovascular events despite homocysteine reduction. Research suggests benefit may be limited to populations without folic acid fortification.
结论
CSPPT showed stroke benefit but not MI benefit. HOPE-2 was negative for cardiovascular events despite homocysteine reduction. Research suggests benefit may be limited to populations without folic acid fortification.
Key Statistics
10
研究数量
40000
受试者
Mixed
等级
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 400 mcg DFE/day
- homocysteinereduction:
- 400-800 mcg/day folic acid (with B12 and B6)
上限: 1,000 mcg/day folic acid from supplements
最佳服用时间: With or without food; consistent daily timing preferred
Safety & Side Effects
已报告的副作用
- ⚠ Generally very well-tolerated
- ⚠ May mask vitamin B12 deficiency at high doses
- ⚠ Rare: mild gastrointestinal discomfort
已知相互作用
- ● Methotrexate (folate may reduce efficacy)
- ● Antiepileptic drugs (phenytoin, carbamazepine — mutual interference)
- ● Vitamin B12 (co-supplementation recommended for homocysteine reduction)
可耐受最高摄入量: 1,000 mcg/day folic acid from supplements
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Folate (Vitamin B9) help with Coronary Artery Disease (CAD)?
How much Folate (Vitamin B9) should I take for Coronary Artery Disease (CAD)?
Are there side effects of Folate (Vitamin B9)?
How strong is the evidence for Folate (Vitamin B9) and Coronary Artery Disease (CAD)?
Related Evidence
其他成分用于 Coronary Artery Disease (CAD)
Folate (Vitamin B9) 用于其他健康状况
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。